Visiomed Group significantly deleverages with the support of its main shareholder, strengthening its investment capacity

VISIOMED GROUP had subscribed to a loan agreement granted by Perpetua Capital on 13 December 2022 for a total amount of €1,750,000. The loan had a maturity of 2 years with an annual interest rate of 9 %.

VISIOMED GROUP and Perpetua Capital have amended the loan agreement, voiding all accrued interest (€215,649 as of the date of the agreement), decreasing the amount due to €1,750,000, i.e. the nominal amount, with a payment period of 30 days following the amendment.

The debt owed by VISIOMED GROUP was repaid by offsetting the nominal amount with the exercise of 13,157,895 BSA Tranche 5, granting Perpetua Capital 13,157,895 new shares.

Following this operation:

•       The financial debt of VISIOMED GROUP is decreased to €5.7 million^[1] from €7.9 million as of 12/31/2023

•      
The share capital of VISIOMED GROUP increased to 3,075,143.14 euros divided into 307,514,314 shares with a par value of 0.01 euros for each share

•       The number of exercisable BSA Tranche 5 is reduced from 16,914,750 to 3,756,855

CONTACTS

Jérôme FABREGUETTES LEIB Fatou-Kiné N'DIAYE Investor Relations Financial Press Relations visiomed@actus.fr  fndiaye@actus.fr Tel: 01 53 67 36 78 Tel: 01 53 67 36 34

© Visiomed Group SA 2024. The brands mentioned are the property of their respective authors. Reproduction prohibited, even partial, without prior authorization.